J&J Ordered To Pay $327M Over Risperdal Marketing
A South Carolina state court judge on Friday ordered a Johnson & Johnson subsidiary to pay $327 million for downplaying the links between its antipsychotic drug Risperdal and diabetes....To view the full article, register now.
Already a subscriber? Click here to view full article